期刊文献+

硫酸阿米卡星注射液及有关物质的HPLC法分析 被引量:25

The analysis of amikacin sulfate injection and its related substances by RP-HPLC
暂未订购
导出
摘要 2,4,6 -三硝基苯磺酸做衍生试剂 ,采用反相高效液相色谱法分析、紫外检测器检测 ,分离、定量了硫酸阿米卡星注射液及有关杂质 A、B、C、D。本法的衍生化产物稳定 ,线性范围为 0 .2~ 2 0 mg/ ml(r=0 .9991) ,平均回收率为 (10 0 .4± 2 .0 ) % ,日内、日间、不同人之间的操作误差分别为 1.2 9%、0 .90 %、0 .6 0 % ,最低检出量为 0 .0 5 6 ng。用本法测定了国内 2 1个厂家 2 4批硫酸阿米卡星注射液的含量 ,并与微生物法结果比较 ,用自身配对 t检验法考察两法结果差异。结果表明 ,绝大多数厂家的产品采用两法测定结果一致 (n=2 2 ) ,但也有个别厂家的产品 ,采用微生物法测定结果明显比本法高 ,其高效液相色谱图显示该类产品中杂质A的含量较高。不同厂家的产品中的杂质种类、含量也有较大差异 ,国产硫酸阿米卡星注射液中最常见的杂质是杂质 The analysis of commercial amkacin sulfate injection from different origins by reverse phase high performance liquid chromatography (RP HPLC) on a Diamonsil C 18 column with UV detection (340nm) was described. The mobile phase consists of 75 volumes of methanol and 25 volumes of a 0.27% solution of potassium dihydrogen phosphate, pH6.5. Samples were derivatized with 2,4,6 trinitrobenzenesulfonic acid. The derivatized products are stable within 8 hours at ambient temperature. The linear ranges were 0.2~20mg/ml ( r =0.9991); mean recovery: (100.4±2.0)%; inter day, intra day relative standard deviations were 0.90% and 1.29%, respectively; the detection limit was 0.056ng. 24 batches of amikacin sulfate injection were determined with this method and microbial assay, respectively. The differences between both methods were negligible for most samples, but in some cases, the results obtained with microbial assay were higher than that of HPLC. The chromatography profile showed there was a kind of antibacterial impurity presenting a large percentage in these special samples, demonstrating the reason of the above differences.
出处 《中国抗生素杂志》 CAS CSCD 北大核心 2001年第5期345-347,392,共4页 Chinese Journal of Antibiotics
关键词 硫酸阿米卡星注射液 含量 测定 有关物质分析 高效液相色谱法 质量控制 Amikacin sulfate injection Determination Related substances HPLC
  • 相关文献

参考文献2

  • 1[1]European Pharmacopoeia Secretarist. European pharmacopoeia, 3rd [S], Strasbourg, European Department for the quality of Medicines within the council of Europe,2000 (Suppl) :267
  • 2[2]The United States Pharmacopeial Convention, Inc. The United States Pharmacopoeia, 24th (II) [S], philadephia, National Publishing, 1999: 107

同被引文献235

引证文献25

二级引证文献98

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部